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Failure to Rescue as an Outcome Metric for Pediatric and Congenital
Cardiac Catheterization Laboratory Programs: Analysis of Data From
the IMPACT Registry
Michael L. O’Byrne, MD, MSCE; Kevin F. Kennedy, MS; Natalie Jayaram, MD, MS; Lisa J. Bergersen, MD, MPH; Matthew J. Gillespie, MD;
Yoav Dori, MD, PhD; Jeffrey H. Silber, MD, PhD; Steven M. Kawut, MD, MS; Jonathan J. Rome, MD; Andrew C Glatz, MD, MSCE

Background-—Risk-adjusted adverse event (AE) rates have been used to measure the quality of pediatric and congenital cardiac
catheterization laboratories. In other settings, failure to rescue (FTR) has demonstrated utility as a quality metric.
Methods and Results-—A multicenter retrospective cohort study was performed using data from the IMPACT (Improving Adult and
Congenital Treatment) Registry between January 2010 and December 2016. A modiﬁed FTR metric was developed for pediatric and
congenital cardiac catheterization laboratories and then compared with pooled AEs. The associations between patient- and
hospital-level factors and outcomes were evaluated using hierarchical logistic regression models. Hospital risk standardized ratios
were then calculated. Rankings of risk standardized ratios for each outcome were compared to determine whether AEs and FTR
identiﬁed the same high- and low-performing centers. During the study period, 77 580 catheterizations were performed at 91
hospitals. Higher annual hospital catheterization volume was associated with lower odds of FTR (odds ratio: 0.68 per 300 cases;
P=0.0003). No association was seen between catheterization volume and odds of AEs. Odds of AEs were instead associated with
patient- and procedure-level factors. There was no correlation between risk standardized ratio ranks for FTR and pooled AEs
(P=0.46). Hospital ranks by catheterization volume and FTR were associated (r= 0.28, P=0.01) with the largest volume hospitals
having the lowest risk of FTR.
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Conclusions-—In contrast to AEs, FTR was not strongly associated with patient- and procedure-level factors and was signiﬁcantly
associated with pediatric and congenital cardiac catheterization laboratory volume. Hospital rankings based on FTR and AEs were
not signiﬁcantly correlated. We conclude that FTR is a complementary measure of catheterization laboratory quality and should be
included in future research and quality-improvement projects. ( J Am Heart Assoc. 2019;8:e013151. DOI: 10.1161/JAHA.119.
013151.)
Key Words: health services research • outcomes research • pediatrics

C

ardiac catheterization remains the gold standard for
hemodynamic evaluation of young patients with cardiac
disease and as a means of intervening for an increasing range
of conditions. Adverse events (AEs) in the pediatric and
congenital cardiac catheterization laboratory (PCCL) are

relatively uncommon. Nonetheless, PCCL procedures are a
source of signiﬁcant morbidity.1,2 Previous efforts to deﬁne
quality metrics have pooled different AEs.3–8 Pooled AEs were
chosen over mortality because deaths following catheterization are rare, and concerns exist regarding (1) attributability of
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What Is New?
• A failure to rescue (FTR) metric was developed speciﬁcally
for the pediatric and congenital catheterization laboratory
setting and compared with pooled adverse events (AEs).
• Risk of pooled AEs was related to participant and procedural
factors, whereas FTR risk was associated with hospital
volume.
• Hospital ranks using risk-adjusted AEs and FTR differed
signiﬁcantly.

What Are the Clinical Implications?
• FTR as a quality metric adds unique information about
programmatic quality.
• FTR should be included in future research studies, qualityimprovement efforts, and evaluations of programmatic
performance.
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deaths to the catheterization procedure, (2) signiﬁcant
medical comorbidity, and (3) frequent crossover to and from
the care of cardiac surgeons.
An important question is whether the risk-adjusted AE rate
is the single, optimal quality measure for PCCL programs.
Failure to rescue (FTR), deﬁned as death following a major AE,
was introduced as an alternative to the pooled AE outcome
metric.9 In diverse settings, FTR has demonstrated attractive
characteristics relative to both pooled AE and mortality rates.
In these settings, signiﬁcant associations have been demonstrated between FTR and known measures of hospital quality,
whereas the factors associated with pooled AEs have been
patient-level factors.9–11 In addition, ranks of hospitals based
on risk-adjusted AEs differ signiﬁcantly from those based on
FTR.11 These ﬁndings suggest that FTR has value in measuring
the quality of care delivered at different hospitals. Although
initially developed in a cohort of adult surgical patients,9 FTR
has been applied in a broad array of medical and surgical
contexts.9,11–23
Using data from the IMPACT (Improving Adult and Congenital Treatment) Registry, we performed a multicenter retrospective cohort study to develop an FTR metric adapted to the
PCCL environment and to determine whether that metric
provided value in addition to that provided by risk-adjusted
AEs. We sought to determine what patient-, procedure-, and
hospital-level factors were associated with risk of complications and FTR and whether hospital rankings based on FTR and
pooled AEs were correlated. We hypothesized (1) that patient
and procedure factors would be associated with the odds of
pooled AEs but not FTR and that, conversely, potential markers
of programmatic quality (speciﬁcally, hospital procedural
volume) would be associated with the odds of FTR but not
DOI: 10.1161/JAHA.119.013151

pooled AEs and (2) that rankings of hospitals by FTR and AEs
would not be signiﬁcantly correlated. Together, these ﬁndings
would show that FTR provided unique information in addition
to that provided by risk-adjusted AEs.

Methods
Data Source
IMPACT is a clinical registry funded by the American College
of Cardiology and managed by the National Cardiovascular
Data Registry with data from 91 pediatric and general
hospitals performing cardiac catheterizations in children and
adults with congenital heart disease at the time of this
analysis. Participating centers collect demographics, medical
and surgical history, procedural information, and AEs through
hospital discharge on all patients undergoing cardiac
catheterization. Data are recorded using standardized data
elements and deﬁnitions. The database is subject to quality
assurance standards.24 The current study used data from
IMPACT v1.0.1. The institutional review board of the Children’s Hospital of Philadelphia reviewed the proposed project
and determined that it did not represent human subjects
research in accordance with the Common Rule (45 CFR
46.102(f)). Data, analytic methods, and study materials will
not be made available to other researchers for the purposes
of reproducing the results or replicating the procedures
because that would not be consistent with the data-use
agreement between the study staff and the American College
of Cardiology Foundation and National Cardiovascular Data
Registry.

Study Population
Cases performed between January 2010 and December 2016
at centers contributing to IMPACT in patients between birth
and 25 years of age were eligible for inclusion. Cases
reported as emergent or salvage status were excluded
because the patients were already in jeopardy; therefore,
these cases would not be informative about the quality of care
in the catheterization laboratory. For the same reasons, cases
involving patients who were already receiving mechanical
circulatory (extracorporeal membrane oxygenation or ventricular assist devices) were also excluded. Although patients
with recent cardiac surgery were potentially at higher risk of
adverse outcomes, their cases represent a common and
important part of clinical practice and so were not excluded
unless urgency of the procedure was classiﬁed as emergency
or salvage. As noted below, statistical adjustment for history
of recent cardiac surgery was performed to mitigate any bias
introduced by differential utilization of catheterization in the
postoperative period between hospitals.
Journal of the American Heart Association
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Data were extracted directly from the IMPACT Registry,
speciﬁcally demographics, medical history (including preprocedure risk factors), hemodynamic data, and details of the
procedure (speciﬁc interventions, anesthesia at start of the
case, device used, and presence of a trainee). AEs recorded in
IMPACT (in-hospital mortality; cardiac arrest; new arrhythmia;
new heart valve regurgitation; tamponade; air embolus; embolic
stroke; device malposition; device embolization; airway event;
blood transfusion; initiation of dialysis; new extracorporeal
membrane oxygenation; new ventricular assist device;
unplanned cardiac, vascular, or other surgery; vascular
complication requiring treatment; repeat catheterization [all
before discharge], and other events) were recorded. Of note,
the registry instructs centers to report only unplanned surgical
and catheterization procedures that are attributable to a
catheterization complication. Hospital procedural volume
was calculated as prorated annual averages, as described
previously.25–27

Deﬁnitions

Downloaded from http://ahajournals.org by on October 27, 2020

FTR was originally deﬁned as death following a complication,
reﬂecting the hospital’s inability to prevent that progression.9
We chose to adapt this deﬁnition to the PCCL environment with
2 changes. First, we counted all deaths occurring within 2 days
from catheterization. In previous FTR studies of surgical
patients, it has been assumed that all deaths within 30 days
were attributable to preceding procedure-related complications.9,12 In the PCCL, patients may undergo technically
successful catheterizations without complication and then
subsequently die during the same hospitalization either after
cardiac surgery or because of progression of their condition. In
a multicenter series, only 10% of deaths within 30 days of PCCL
were attributable (after adjudication) to the catheterization.28
We reviewed the incident and cumulative rate of deaths after
catheterization and found that the 2-day mark was a natural
qualitative cut point in the incidence of postcatheterization
deaths. This approach was also consistent with previous
research.25,26 These choices were made to minimize inclusion
of deaths due to other causes and were necessary because it is
not possible to review and adjudicate all deaths and other
events in IMPACT. Deaths and other events that occurred in the
same hospitalization but after an elective surgical procedure
were not included regardless of timing. This deﬁnition of deaths
was used for both FTR and pooled AEs. Second, because we
intended to measure the quality of catheterization laboratory
care, we included other catastrophic AEs for which care
escalated beyond the capacity of the catheterization laboratory
team in our list of failures (Table 1). We acknowledge that in
some cases, mechanical circulatory support was initiated
electively or semielectively in catheterization patients. For our
DOI: 10.1161/JAHA.119.013151

analysis, these failure events were also considered separately
as catastrophic AE.
Next we evaluated the possible AEs after catheterization
and created a list of those that could potentially lead to a
catastrophic adverse outcome (Table 1). Blood transfusion
was the most common AE noted in the registry, but it was not
included as a proximal event because it was judged not likely
to be directly and independently responsible for a catastrophic event. This choice was supported by the observation
that removing it from the list of preceding events did not
change the precedence rate (see below). Of note, repeated
catheterization and surgeries are recorded in IMPACT only
when the procedure is attributable to a catheterization
complication. Consequently, even if no other AE were
recorded, cases in which unplanned surgeries (cardiac,
vascular, or other) or repeated catheterizations were reported
were recorded as having both proximal and catastrophic AEs.
The proportion of these unplanned procedures with proximal
events is reported in Table S1.
To evaluate whether the list of proximal events was
comprehensive, we calculated the proportion of catastrophic
AEs with a preceding proximal event (the precedence rate). In
this sample, the precedence rate was 70% (687/977). This
rate is close to what has been seen in other studies using
FTR.22 It may also reﬂect that patients arriving in the PCCL are
potentially more medically complicated (with greater possibility of deterioration independent of a preceding
complication) than older patients undergoing isolated surgical
procedures.
To summarize, the deﬁnition of our modiﬁed FTR metric is
the occurrence of one of the catastrophic AEs after one of the
proximal events.

Statistical Analysis
Descriptive statistics were calculated. Observed rates for total
AEs, proximal AEs, catastrophic AEs, and FTR were calculated.
The goals of subsequent analyses were to compare the
characteristics of the different study outcomes as quality
metrics. First, generalized linear models with binomial
frequency distribution, adjusted for the listed covariates as
ﬁxed effects and clustered by hospital (using a random
intercept for each hospital, implemented using glimmix in SAS
v9.4; SAS Institute), were calculated to evaluate the degree to
which patient, procedure, and hospital factors were associated with each outcome of interest. Additional random effects
(eg, random slope) and interaction were not explored. FTR
was the primary outcome of interest. Pooled AEs (including
and excluding deaths), proximal AEs, and catastrophic AEs
were secondary outcomes. We hypothesized that odds of
pooled AEs would be associated with patient and procedural
factors and that odds of FTR would not be associated with
Journal of the American Heart Association
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these factors. Moreover, we sought to determine whether
markers of hospital quality were associated with risk of these
outcomes, hypothesizing that odds of FTR would be associated with these factors and that odds of pooled AEs would
not. To our knowledge, no hospital characteristics are
unequivocally associated with the quality of a PCCL program.
Hospital procedural volume has been associated with
improved outcomes across disparate medical ﬁelds.29 Consequently, hospital annual catheterization volume was used as
the primary hospital characteristic of interest.
Covariates were identiﬁed before model calculation and
included patient, procedure, and hospital characteristics.
Patient characteristics were age by category, sex, race,
previous cardiac surgery in the prior 30 days, cardiac
catheterization in the prior 30 days, preprocedure inotropes,
preprocedure vasodilator, preprocedure sepsis, chronic lung
disease, genetic syndrome, renal insufﬁciency, hemodynamic
vulnerability (as deﬁned previously7), low systemic arterial
saturation, low mixed venous saturation, high mean pulmonary
pressure, and elevated systemic ventricular end-diastolic
pressure. Procedure characteristics were procedural risk
category as deﬁned in the Catheterization for Congenital
Heart Disease Adjustment for Risk Method,4,6,7 use of general
anesthesia versus conscious sedation, and presence of a
trainee. Hospital characteristics were procedural volume >35%
adult and academic or university hospital. These separate
covariates were used rather than the IMPACT risk-adjustment
model30 because that risk model combines procedures and
patient ages. It was also not clear, a priori, that this component
of the risk model would be equally applicable to all outcomes,
and it was not desirable to forego information about both ages
and procedure types. Hemodynamic vulnerabilities were
considered individually rather than as a number of vulnerabilities, as had been done previously,7 to avoid bias from missing
data and to evaluate whether the effect of hemodynamic
vulnerabilities differed for AEs and FTR. To determine whether
either deviation from the validated risk adjustment model
introduced bias, sensitivity analyses were performed using the
most recent procedure codes and the sum of the number of
hemodynamic vulnerabilities present. No changes in the
observed results were seen (data not shown). A third
sensitivity analysis was performed by recalculating all models
excluding patients with cardiac surgery in the prior 30 days.
Again, no changes in the reported results were seen (data not
shown). The threshold of >35% cases in adults was chosen
based on examination of the distribution of adult cases in the
hospitals contributing data to the IMPACT Registry, which
identiﬁed a qualitatively different cluster of hospitals, as has
been reported previously.31,32
The primary model used FTR as an outcome. Secondary
analyses planned before the beginning of the analyses
included calculating analogous models for the risk of (1) all

Table 1. Outcomes
Proximal events
New arrhythmia
New heart valve regurgitation
Cardiac tamponade
Air embolus
Embolic stroke
Device malposition
Device embolization
Airway event
Initiation of dialysis
Unplanned cardiac, vascular, or other surgery (due to catheterization
complication)*
Vascular complication requiring treatment (due to catheterization
complication)*
Repeated catheterization (due to catheterization complication)*
Other major events
Catastrophic events
Death within 2 days of catheterization
Cardiac arrest
Initiation of mechanical circulatory support
Initiation of extracorporeal membrane oxygenation
Unplanned cardiac, vascular, or other surgery (due to catheterization
complication)*
Vascular complication requiring treatment (due to catheterization
complication)*
Repeat catheterization (due to catheterization complication)*
Outcomes were determined using IMPACT (Improving Adult and Congenital Treatment)
Registry standard deﬁnitions. Failure to rescue was deﬁned as a catastrophic adverse
outcome occurring in a case with a proximal event. Pooled adverse events encompass
any of the proximal or catastrophic events.
*These events are deﬁned as being due to a catheterization complication, so they were
included in both proximal and catastrophic events.

AEs, (2) catastrophic AEs, (3) all AEs excluding death, and (4)
proximal AEs. It was also recognized that the database
includes multiple catheterization procedures in individual
subjects. To address this, a sensitivity analysis restricted to
the ﬁrst catheterization of each participant was performed for
our primary model, as in previous studies.25,26 To ensure that
the associations between hospital factors and outcomes were
not due to correlation between these factors, additional
models were calculated with only 1 of the 3 center factors for
each outcome, conﬁrming that no change in the observed
associations was seen.
Next we sought to evaluate whether hospital rankings
based on case-mix–adjusted AEs and FTR identiﬁed the same
high- and low-performing hospitals. For each hospital, a risk
standardized ratio (RSR) was calculated, and hospitals were
ranked. RSR is a ratio of the predicted outcome for each
Journal of the American Heart Association
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Results
Study Population
Downloaded from http://ahajournals.org by on October 27, 2020

Over the study period, 77 580 procedures were performed on
53 056 individual participants at 91 hospitals (Figure 1). Of the
cases included, the median age of participants was 4 years
(interquartile range: 0–12 years). Overall, 47% were female, and
70% were white. Patient and procedural characteristics are
summarized in Table 2. Of the hospitals contributing data to
IMPACT, 46% (42/91) were university or teaching hospitals,
and 10% (9/91) had a large proportion of their reported
catheterizations in adults (>35%). The median annual catheterization volume of hospitals included in the study was 284 cases
(interquartile range: 117–416 cases).

Outcomes
AEs occurred in 4.7% of cases overall (Table 3). The risk of the
composite outcome for catastrophic AEs was 1.2%. The risk of
proximal AEs was 4.4% (frequencies of individual proximal AEs
are summarized in Table S2). The risk of catastrophic AEs
after proximal AEs (observed FTR) was 20.3%.

Factors Associated With FTR, AE, and
Catastrophic AE Rates
Hierarchical models were calculated for each major outcome
(Table 4). These models demonstrated that the adjusted risk
of FTR was signiﬁcantly lower at higher volume hospitals
DOI: 10.1161/JAHA.119.013151

(odds ratio [OR] per 300 cases: 0.68; 95% CI, 0.55–0.84;
P=0.0003). The risk of FTR was lower at hospitals with a high
proportion of cases in adults (OR: 0.16; 95% CI, 0.05–0.55;
P=0.003). Preprocedural receipt of inotropes (OR: 3.05; 95%
CI, 2.43–3.83; P<0.0001), renal insufﬁciency (OR: 2.42; 95%
CI, 1.54–3.79; P=0.0001), and low mixed venous saturation
(OR: 1.39; 95% CI, 1.09–1.79; P=0.009) were positively
associated with FTR, whereas surgery in the prior 30 days
(OR: 0.16; 95% CI, 0.1–0.25; P<0.0001) was negatively
associated with FTR. Procedure risk categories 2 and 3 were
negatively associated with FTR relative to risk category 1 (OR:
0.70; 95% CI, 0.51–0.95; P=0.02; and OR: 0.72; 95% CI, 0.52–
0.99; P=0.04, respectively).
In contrast, composite AEs were not signiﬁcantly associated with procedural volume (P=0.53) but were signiﬁcantly
associated with patient-level factors (age, preprocedure
inotropes, recent surgery or catheterization, genetic syndrome, renal insufﬁciency, and previously identiﬁed markers
of hemodynamic vulnerability) and procedure-level factors
(procedure group and use of general anesthesia).
A similar pattern of positive association was seen between
many of the previously identiﬁed patient-level factors (age,
inotropes, renal insufﬁciency, 3 of the 4 markers of hemodynamic vulnerability) and procedure-level factors (procedure
group 4 and receipt of general anesthesia) and catastrophic
adverse outcome. Increasing PCCL volume was associated
with reduced odds of catastrophic adverse outcome (OR:
0.79; 95% CI, 066–0.94; P=0.009).
Analogous models were calculated for AEs with deaths
excluded and proximal AEs (Table S3), with both models
resembling the model for all AEs. A sensitivity analysis was
performed for the FTR model restricted to the ﬁrst catheterization in the sample with no signiﬁcant changes in the point
estimates (Table S4).
To evaluate interactions between hospital factors, models
including only procedural volume, adult volume >35%, and
teaching hospital versus non–teaching hospital were calculated and demonstrated no differences from the primary
model (Tables S5–S7).

Ranking Programs
For each hospital, standardized ratios of observed to expected
events were calculated for FTR, all AEs, and catastrophic AEs.
There was no correlation between hospital rankings by RSR
for all AEs and RSR for FTR (Spearman r= 0.08, P=0.46; if
deaths are excluded, Spearman r= 0.14, P=0.23). In contrast, hospital ranking based on RSR for FTR and RSR for
catastrophic AEs were strongly correlated (Spearman r=0.65,
P<0.05; Figure 2).
Rank correlations based on hospital catheterization volume
and our outcomes were also performed. There was a
Journal of the American Heart Association
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hospital to the expected rate for a hospital with similar case
mix based on previously calculated hierarchical models.
Correlation between rankings of the RSR for FTR, composite
AEs, and catastrophic AEs were evaluated using Spearman
rank correlation coefﬁcients, as has been done in previous
studies using FTR.10,22 Similarly, the association between the
aforementioned outcomes and hospital PCCL volume was also
evaluated.
Not all hemodynamic factors were recorded in every case.
To avoid the potential bias introduced by excluding cases with
missing hemodynamics, a variable for missing was included,
as described previously.27,33 Multiple imputation was not used
because the missing data were not plausibly predicted by
collected data. As described, the primary analysis and
secondary analyses (exposure, outcome, and covariates) were
deﬁned before analysis. To avoid bias, no post hoc model
reﬁnement was performed. No formal steps were taken to
penalize for multiple comparisons, and analyses beyond the
primary analyses should be considered exploratory. A threshold for statistical signiﬁcance was set at P<0.05. All data
analysis was performed using SAS 9.4.

Failure to Rescue in Pediatric Catheterization
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Figure 1. Study population. ECMO indicates extracorporeal membrane oxygenation; VAD, ventricular
assist device.

signiﬁcant association between the ranks of hospitals based
on procedural volume and RSR for FTR (r= 0.28, P=0.01;
Figure 3) but not between annual catheterization volume and
RSR for all AEs (P=0.32). There was of note a signiﬁcant
association between procedural volume rank and RSR for
catastrophic volume (r= 0.21, P=0.048; data not shown).

Discussion
Downloaded from http://ahajournals.org by on October 27, 2020

In this retrospective multi-center cohort study, we sought to
evaluate a modiﬁed version of FTR as a potential quality
metric for PCCL programs. We compared its properties with a
composite outcome of pooled major AEs that has been the
standard in previous risk-adjustment models.6,7,27 As in
previous studies, the odds of pooled AEs were associated
with a number of patient- and procedure-level factors but not
hospital factors (eg, procedural volume). FTR, in contrast,
occurs only after an AE, and we expected it to be less
inﬂuenced by case mix and more affected by the quality of the
care team. As expected, the odds of FTR was associated with
a smaller number of patient factors (that appeared to
independently affect the risk of progressing from a relatively
minor AE to a catastrophic one). Rankings of hospitals using
case-mix–adjusted AEs and rankings based on FTR were not
correlated. Finally, rankings of hospitals by RSR for FTR were
correlated with PCCL volume (a potential marker of hospital
quality), whereas those for AEs were not. These ﬁndings
suggest that FTR provides information about hospital performance not captured by case-mix–adjusted AE and should be
included in future research and quality-improvement projects.
From a conceptual standpoint, several properties of FTR
make it well suited as a measurement of quality for PCCL
programs. The case mix in PCCL programs is complex, not
only because of a broad range of patient characteristics
DOI: 10.1161/JAHA.119.013151

(cardiac diagnoses, noncardiac conditions, and hemodynamic
instability) but also because of a broad range of procedureassociated risk.3–5,7 The risk of AEs is strongly associated
with these factors. FTR is associated with a much narrower
range of these factors but is associated with procedural
volume, a potential marker of programmatic quality. As a
factor relatively independent of case mix, FTR may provide
better discrimination of programmatic quality. This idea is
supported by the fact that rankings based on risk-adjusted
pooled AEs do not correlate with those based on FTR, but
rankings based on catastrophic AEs do. A possible explanation is that a greater number of AEs included in the composite
outcomes are relatively minor. These relatively minor AEs are
associated with the speciﬁc patient and procedure but do not
appear to be associated with hospital characteristics. Even
after case-mix adjustment, these AEs (and thus composite
AEs) may continue to be more reﬂective of case mix than FTR
or catastrophic adverse outcomes.
To date, there has been greater experience in using casemix–adjusted AEs as a metric for adult and pediatric or
congenital cardiac surgery. However, several concerns have
been raised about the use of risk-adjustment models to
evaluate and report the quality of congenital heart surgery
programs. First, risk-adjustment models that are derived using
large data sets may have excellent test characteristics but
perform less well in discriminating between individual programs.34–36 There is a possibility of a ceiling effect for the
highest risk patients, who are not captured in even the best
risk-adjustment model.35,36 Even detailed models may not be
able to account for all possible risk factors (and combinations
of risk factors that may interact). The proposed FTR metric
excludes the highest risk patients (emergent and salvage
procedures) to avoid some of these concerns. There are also
concerns that risk models derived using large data sets will
Journal of the American Heart Association
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Table 3. Outcomes

Characteristic

Result

Outcome

Result, % (n)

No. of cases

77 580

Any AE

4.7 (3682)

No. of participants

53 056

Catastrophic adverse outcome

1.2 (960)

No. of hospitals

91

Death within 2 d

0.2 (141)

Age, y, median (IQR)

4.0 (0–12)

Cardiac arrest

0.6 (465)

Initiation of ECMO/VAD

0.2 (138)

Unplanned cardiac operation
due to catheterization complication

0.3 (232)

Unplanned vascular operation due
to catheterization complication

0.1 (41)

Unplanned other operation due
to catheterization complication

0.2 (153)

Unplanned catheterization due
to catheterization complication

0.3 (252)

Age group
<30 d

5 (4010)

>30 d to 1 y

21 (16 392)

1–8 y
8–18 y
>18 y
Female sex

38 (29 104)
28 (21 894)
8 (6180)
47 (36 108)

Race
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White

70 (54 648)

Proximal adverse outcomes

4.4 (3416)

Black

17 (13 426)

FTR

20.3 (694/3416)

Other

12 (9506)

Cardiothoracic surgery within 30 d prior

2 (1568)

Cardiac catheterization within 30 d prior

4 (3112)

Chronic lung disease

6.5 (5009)

Single ventricle

21 (16 018)

Genetic syndrome

12 (8912)

Renal insufficiency

2.8(2166)

Preprocedure inotropes

6.8 (5273)

Preprocedure vasodilator

9.6 (7456)

Hemodynamic vulnerability
Systemic arterial saturation

27 (19 542/71 500)

Mixed venous saturation

13 (8981/68 853)

Pulmonary artery pressure

18 (11 184/62 658)

Systemic ventricular
end-diastolic pressure

6 (3158/50 575)

Procedure risk category
1

41 (31 966)

2

33 (25 586)

3

19 (14 625)

4

7 (5381)

Sedation strategy
General anesthesia

87 (67 564)

Conscious sedation

12 (9144)

Trainee present

63 (48 743)

Case performed at hospital
with >35% adult
catheterization volume

2 (1300)

Case performed at a teaching institution

93 (71 594)

Data are shown as % (n) except as noted. IQR indicates interquartile range.
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Table 2. Study Population

AE indicates adverse event; ECMO, extracorporeal membrane oxygenation; FTR, failure
to rescue; VAD, ventricular assist device.

have unreliable results when event rates are small for
individual procedures.34–36 Finally, judging hospitals that do
not engage in the entire spectrum of risk based on their
performance with less risky patients or procedures produces
an illusory estimate of their quality, as excellent performance
in a lower risk pool does not predict similar results for higher
risk cases.34–36 The proposed FTR metric studies the progress
from AEs to a catastrophic AE and (as demonstrated in the
current study) is relatively independent of patient- and
procedure-deﬁned risk proﬁles. Consequently, FTR may be
less subject to differences in hospital case mix than pooled AE.
A normative beneﬁt of using FTR as a quality metric is that
it encourages accurate reporting of relatively minor AEs,
which might otherwise be reported differentially. This is
because FTR removes a disincentive for reporting these
(potentially equivocal) events and, because they are in the
denominator of FTR, actually incentivizes reporting them.
Catastrophic AEs are less equivocal, and reporting of them is
less likely to be subjective and affected by incentives imposed
by sharing of outcomes and potential public reporting. More
important, using FTR as an outcome also ameliorates the
disincentive to take on high-risk or complex interventions
and/or medically complex patients, who are associated with
AE risk out of proportion to that predicted by risk-adjustment
models. Use of an FTR-based ranking system places the
emphasis of the metric on whether patients can be successfully shepherded through the PCCL without an AE progressing
to a more catastrophic one, which is in greater alignment with
the values of the ﬁeld as a whole.
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Table 4. Multivariable Models for Outcomes of Interest
FTR

All AEs

Catastrophic AEs

OR (95% CI)

P Value

OR (95% CI)

P Value

OR (95% CI)

P Value

<30 d

0.82 (0.56–1.18)

0.29

2.62 (2.27–3.03)

<0.0001

2.25 (1.71–2.96)

<0.0001

30 d to 1 y

1.21 (0.90–1.62)

0.21

1.55 (1.39–1.73)

<0.0001

1.92 (1.55–2.39)

<0.0001

1–8 y

1 (NA)

NA

1 (NA)

NA

1 (NA)

NA

Age group

8–18 y

1.29 (0.97–1.73)

0.08

0.99 (0.89–1.10)

0.86

1.08 (0.87–1.34)

0.51

≥18 y

1.28 (0.80–2.06)

0.31

0.91 (0.76–1.09)

0.31

1.04 (0.73–1.48)

0.82

Male sex

0.89 (0.74–1.07)

0.20

1.05 (0.98–1.13)

0.14

0.96 (0.84–1.09)

0.52

Race
White

1 (NA)

NA

1 (NA)

NA

1 (NA)

NA

Black

1.04 (0.81–1.35)

0.75

1.02 (0.98–1.13)

0.14

1.06 (0.88–1.26)

0.56

Other

1.21 (0.9–1.62)

0.22

1.00 (0.89–1.12)

0.95

1.21 (0.98–1.49)

0.08

Surgery (previous 30 d)

0.16 (0.1–0.25)

<0.0001

10.15 (8.80–11.69)

<0.0001

1.05 (0.70–1.56)

0.82

Catheterization (previous 30 d)

1.24 (0.71–2.15)

0.45

0.65 (0.53–0.80)

<0.0001

1.00 (0.69–1.46)

0.98

Inotrope

3.05 (2.43–3.83)

<0.0001

2.37 (2.14–2.62)

<0.0001

4.94 (4.20–5.82)

<0.0001

Vasodilators

0.96 (0.72–1.27)

0.77

1.02 (0.91–1.14)

0.79

1.08 (0.89–1.31)

0.45

Sepsis

2.19 (0.94–5.07)

0.07

1.16 (0.78–1.72)

0.47

1.62 (0.94–2.79)

0.08

Chronic lung disease

0.63 (0.43–0.90)

0.01

0.98 (0.86–1.12)

0.79

0.8 (0.61–1.03)

0.09

Genetic syndrome

0.76 (0.58–0.99)

0.05

1.22 (1.11–1.35)

<0.0001

1.01 (0.83–1.23)

0.91

Renal insufficiency

2.42 (1.54–3.79)

0.0001

1.28 (1.05–1.58)

0.02

1.98 (1.47–2.68)

<0.0001

Low vs normal

0.95 (0.77–1.19)

0.68

1.14 (1.05–1.24)

0.003

1.08 (0.92–1.27)

0.36

Low vs missing

1.17 (0.8–1.7)

0.42

0.97 (0.83–1.13)

0.69

1.07 (0.82–1.40)

0.63

Low vs normal

1.39 (1.09–1.79)

0.009

1.53 (1.38–1.69)

<0.0001

1.85 (1.54–2.21)

<0.0001

Low vs missing

1.22 (0.88–1.70)

0.22

1.20 (1.05–1.38)

0.006

1.39 (1.10–1.77)

0.007

High vs normal

1.00 (0.78–1.29)

1.00

1.41 (1.28–1.56)

<0.0001

1.56 (1.30–1.86)

<0.0001

High vs missing

1.11 (0.85–1.43)

0.44

1.35 (1.22–1.49)

<0.0001

1.53 (1.27–1.84)

<0.0001

Preprocedure medications

Preprocedure conditions
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Systemic arterial saturation

Mixed venous saturation

Pulmonary artery pressure

Systemic ventricular end-diastolic pressure
High vs normal

0.86 (0.57–1.29)

0.46

1.45 (1.23–1.69)

<0.0001

1.43 (1.09–1.88)

0.009

High vs missing

1.15 (0.93–1.43)

0.21

1.03 (0.94–1.11)

0.56

1.13 (0.97–1.32)

0.13

1

1 (NA)

NA

1 (NA)

NA

1 (NA)

NA

2

0.70 (0.51–0.95)

0.02

1.54 (1.37–1.73)

<0.0001

1.03 (0.81–1.30)

0.81

3

0.72 (0.52–0.99)

0.04

1.70 (1.51–1.92)

<0.0001

1.14 (0.9–1.45)

0.28

4

0.89 (0.62–1.29)

0.55

2.05 (1.78–2.36)

<0.0001

1.49 (1.14–1.96)

0.004

Trainee present

0.96 (0.74–1.23)

0.72

1.04 (0.93–1.16)

0.52

1.01 (0.84–1.22)

0.89

General anesthesia vs IV sedation

1.17 (0.81–1.7)

0.40

1.28 (1.12–1.46)

0.0004

1.41 (1.09–1.84)

0.01

Procedure group

Continued

DOI: 10.1161/JAHA.119.013151

Journal of the American Heart Association

8

Failure to Rescue in Pediatric Catheterization

O’Byrne et al
ORIGINAL RESEARCH

Table 4. Continued
FTR

All AEs

Catastrophic AEs

OR (95% CI)

P Value

OR (95% CI)

P Value

OR (95% CI)

P Value

Hospital characteristics
Adult cases >35% of total

0.16 (0.05–0.55)

0.003

1.37 (0.82–2.28)

0.23

0.73 (0.34–1.57)

0.42

University hospital

1.01 (0.72–1.41)

0.95

1.22 (0.97–1.52)

0.09

1.16 (0.87–1.53)

0.31

Annual catheterization volume (per 300 cases)

0.68 (0.55–0.84)

0.0003

0.95 (0.83–1.10)

0.53

0.79 (0.66–0.94)

0.009

AE indicates adverse event; FTR, failure to rescue; IV, intravenous; NA, not available; OR, odds ratio.
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Our modiﬁed FTR metric also addresses the issue of
attributability of postprocedure mortality, which has been
questioned in the literature.28 PCCL patients differ from adult
general surgical patients both in terms of the severity of their
medical disease and the fact that these patients frequently
undergo cardiothoracic surgery. Evaluating attributability is
possible with review of the chart, but prospective adjudication
of these events is challenging. In the IMPACT Registry, most
of the component events in the current pooled AE composite
outcome are recorded without regard to attributability. To
improve the attributability of FTR to events in the catheterization laboratory, the proposed FTR metric counts deaths
only if they occur within 2 days of catheterization and
incorporates severe AEs that occur in combination with a
more minor event in the catheterization laboratory or that
were explicitly judged to be due to an event in the
catheterization laboratory. We acknowledge that this strategy
does not solve the issue of attributability, but it is a potential
improvement over the current approach.
A factor that limited our ability to test the relative merits of
composite AEs, FTR, and catastrophic AEs as quality metrics
was the lack of validated hospital- or program-level markers of
quality. In the absence of any gold standard measures of
hospital quality, we sought to use hospital annual PCCL
volume as a potential marker of quality because procedural
volume has been associated with superior outcomes across a
broad swath of medical ﬁelds.29 Studies evaluating the
volume–outcome relationship in PCCL have had equivocal
results. A signiﬁcant association between increasing procedural volume and reduced risk of catastrophic adverse
outcomes has been demonstrated in several studies,25,26
but when the composite outcome used included a broader
range of less severe outcomes, the association was not
seen.27 To clarify this, in the current study, we separately
analyzed the associations between volume and risks of (1)
FTR, (2) all AEs, and (3) catastrophic AEs. A signiﬁcant
association was demonstrated between procedural volume
and the risk of FTR or catastrophic outcomes but not all AEs.
Furthermore, there was a signiﬁcant correlation of the ranks
of hospitals by procedural volume with standardized RSR for
FTR (and no such association was seen with RSR for all AEs).
DOI: 10.1161/JAHA.119.013151

This ﬁnding by itself does not demonstrate that FTR is a
superior outcome measure to all case-mix–adjusted AEs.
However, the association suggests that FTR has a stronger
association with programmatic quality because it appears to
be inﬂuenced by center-level factors rather than patient- and
procedure-level factors. As the ﬁeld progresses, in addition to
comparing programs, future research should identify programmatic practices associated with improved outcomes.
Future research evaluating other aspects of experience (eg,
operator experience) would be useful but are not feasible at
this time. At this point, we would recommend that both FTR
and composite AEs be used in these studies.
The ﬁnding that hospitals with large proportions of adult
patients were associated with reduced FTR was not anticipated. These hospitals are likely general hospitals with
catheterization laboratory volume that includes coronary and
structural heart cases (which are not recorded in IMPACT) on
top of their recorded PCCL (underestimating their “true”
volume). The observed association may be a correction for
this underestimation of volume or some other factor (eg
structures or processes present in institutions that perform
other structural interventions such as transcatheter aortic
valve replacement). Further research is necessary to clarify
the factors from this association arises.
Further research is also necessary to evaluate the relative
merits of FTR and traditional metrics of quality. Several other
large data sets contain detailed information about PCCL
procedures. Reevaluating this model in those databases may
be a useful step in demonstrating its validity.
This study has several other limitations. It was an
observational retrospective study, and causal inference is
limited in this design. Identiﬁed associations do not imply
causation. Moreover, there is always the risk of unmeasured
confounding. Another concern regarding the implementation
of FTR as a quality metric is that FTR is a relatively rare
event, making quarterly reporting challenging. However, we
would contend that for measuring the quality of a hospital
program, it is paramount to ﬁnd a metric with maximum
utility and then to measure it over an adequate period to
measure performance precisely. In addition, using catastrophic AEs (instead of FTR) does not increase statistical
Journal of the American Heart Association
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Figure 2. Correlation of standardized risk of all adverse events (AEs), failure to rescue (FTR), and catastrophic AEs. Scatter plots depict the
association between hospital risk standardized ratio (RSR) for catastrophic AEs and FTR (A), all AEs and FTR (B), and all AEs with death excluded
and FTR (C). Ranks of RSRs for FTR and catastrophic outcome demonstrate signiﬁcant correlation (Spearman r=0.65, P<0.05), whereas there
was no signiﬁcant correlation between RSRs for all AEs and FTR, regardless of whether deaths were included (P=0.46) or excluded (0.23).
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power (which depends on the number of events, which is
similar between catastrophic AEs and FTR, not the rate of
occurrence). As for quality-improvement efforts, low event
rates would make it a less agile measure. At the level of an
individual catheterization laboratory, consideration of both
FTR and a carefully selected pool of signiﬁcant AEs may
be the best means of maintaining quality. Finally, the
study was performed using the IMPACT Registry, and the
deﬁnitions of exposures, outcomes, and covariates are
deﬁned by those available in the database. As new versions

of the registry are developed, updating the FTR metric to
reﬂect available data (especially about outcomes) will be
important.
Despite these limitations, we conclude that, as an outcome
metric, FTR provides additional information that is not
contained in case-mix–adjusted AEs. FTR is complementary
to case-mix–adjusted AEs, offering a distinct perspective on
identifying high- and low-performing centers. We conclude
that FTR should be included along with pooled AEs in future
research and quality-improvement efforts.

Figure 3. Correlation of hospital volume and risk standardized ratio (RSR) of failure to rescue (FTR). This
scatterplot compares hospital annual volume (x-axis) and RSR for FTR. There is a signiﬁcant association
between hospital rank in terms of volume and FTR (r= 0.28, P=0.01), with higher hospital volume
associated with improved (ie, lower) risk of failure. No signiﬁcant correlation is seen between ranks for
hospital volume and RSR for all adverse events (P=0.32, not shown).
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Table S1. Unplanned interventions and preceding other events.
Event
Unplanned cardiac surgery due to catheterization complication
Unplanned other surgery due to catheterization complication
Unplanned vascular surgery due to catheterization complication
Unplanned repeat cardiac catheterization due to catheterization
complication

Preceding event % (n)
53% (122/232)
31% (47/153)
71% (36%)
35% (89)
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Table S2. Individual proximal adverse events.
Proximal adverse outcomes
New arrhythmia requiring cardioversion
New arrhythmia requiring antiarrhythmic medication
New arrhythmia requiring pacemaker
New heart valve regurgitation
Cardiac tamponade
Air embolus
Embolic stroke
Device malposition/embolization
Airway event
Initiation of dialysis
Bleeding event
Vascular complications

4.4% (3,416)
0.5% (352)
0.9% (702)
0.2% (155)
0.06% (49)
0.08% (65)
0.04% (29)
0.05% (37)
0.3% (257)
0.5% (357)
0.02% (18)
1.0% (770)
0.7% (541)
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Table S3. Other multivariable models of adverse events.

Composite AE excluding
deaths
OR (95% CI)
p
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Age group
<30 days
30 days to 1 year
1 year to 8 years
8 years to 18 years
≥18 years
Male sex
Race
White
Black
Other
Surgery (previous 30 days)
Catheterization (previous 30
days)
Preprocedure medications
Inotrope
Vasodilators
Preprocedure conditions
Sepsis
Chronic lung disease
Genetic syndrome
Renal insufficiency
Systemic arterial saturation
Low vs. normal
Low vs. missing
Mixed venous saturation
Low vs. normal
Low vs. missing
Pulmonary artery pressure
High vs. normal
High vs. missing
Systemic ventricular enddiastolic pressure
High vs. normal
High vs. missing
Procedure group
1
2
3
4
Trainee Present
General anesthesia vs. IV
sedation
Hospital characteristics
Adult cases >35% of total
University hospital
Annual catheterization volume
(per 300 cases)

Proximal adverse events
OR (95% CI)

p

2.36 (2.02 to 2.74)
1.44 (1.28 to 1.61)
1 (n/a)
1.01 (0.9 to 1.13)
0.92 (0.76 to 1.11)
1.07 (0.99 to 1.15)

<0.0001
<0.0001
n/a
0.87
0.40
0.08

2.53 (2.19 to 2.94)
1.50 (1.35 to 1.68)
1 (n/a)
1.01 (0.9 to 1.13)
0.92 (0.76 to 1.11)
1.07 (1.00 to 1.15)

<0.0001
<0.0001
n/a
0.87
0.37
0.06

1 (n/a)
0.99 (0.89 to 1.10)
0.96 (0.85 to 1.08)
10.45 (9.04 to 12.07)
0.68 (0.55 to 0.84)

n/a
0.80
0.47
<0.0001
0.0003

1 (n/a)
1.02 (0.92 to 1.13)
0.97 (0.86 to 1.09)
11.32 (9.81 to 13.06)
0.63 (0.51 to 0.78)

n/a
0.76
0.60
<0.0001
<0.0001

1.87 (1.67 to 2.09)
0.95 (0.84 to 1.08)

<0.0001
0.45

2.13 (1.92 to 2.37)
0.96 (0.85 to 1.08)

<0.0001
0.51

0.88 (0.55 to 1.41)
0.96 (0.83 to 1.11)
1.21 (1.09 to 1.34)
1.11 (0.88 to 1.40)

0.59
0.58
0.0005
0.39

1.06 (0.69 to 1.62)
1.00 (0.87 to 1.15)
1.23 (1.11 to 1.36)
1.27 (1.02 to 1.57)

0.79
0.97
<0.0001
0.03

1.12 (1.02 to 1.22)
0.95 (0.81 to 1.12)

0.02
0.55

1.15 (1.05 to 1.25)
0.96 (0.82 to 1.12)

0.003
0.60

1.47 (1.32 to 1.6)
1.14 (0.99 to 1.320

<0.0001
0.07

1.47 (1.33 to 1.63)
1.17 (1.33 to 1.63)

<0.0001
<0.0001

1.23 (1.11 to 1.37)
1.4 (1.18 to 1.66)

<0.0001
<0.0001

1.34 (1.22 to 1.49)
1.31 (1.18 to 1.46)

<0.0001
<0.0001

1.40 (1.18 to 1.66)
0.98 (0.89 to 1.07)

0.0001
0.59

1.36 (1.15 to 1.60)
1.02 (0.93 to 1.11)

0.0004
0.68

1 (n/a)
1.65 (1.46 to 1.86)
1.85 (1.63 to 2.1)
2.26 (1.95 to 2.62)
1.07 (0.95 to 1.20)
1.22 (1.05 to 1.40)

n/a
<0.0001
<0.0001
<0.0001
0.26
0.008

1 (n/a)
1.61 (1.42 to 1.81)
1.81 (1.59 to 2.05)
2.18 (1.88 to 2.52)
1.05 (1.12 to 1.48)
1.29 (1.12 to 1.48)

n/a
<0.0001
<0.0001
<0.0001
0.40
0.0005

1.32 (0.78 to 2.22)
1.24 (0.98 to 1.56)
0.95 (0.82 to 1.10)

0.30
0.07
0.48

1.17 (0.68 to 2.02)
1.23 (0.97 to 1.57)
0.95 (0.81 to 1.10)

0.57
0.08
0.48

Table S4. Failure to rescue model restricted to first catheterization per individual (n=53,056).
Failure to rescue
OR (95% CI)
p
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Age group
<30 days
30 days to 1 year
1 year to 8 years
8 years to 18 years
≥18 years
Male sex
Race
White
Black
Other
Surgery (previous 30 days)
Catheterization (previous 30
days)
Preprocedure medications
Inotrope
Vasodilators
Preprocedure conditions
Sepsis
Chronic lung disease
Genetic syndrome
Renal insufficiency
Systemic arterial saturation
Low vs. normal
Low vs. missing
Mixed venous saturation
Low vs. normal
Low vs. missing
Pulmonary artery pressure
High vs. normal
High vs. missing
Systemic ventricular enddiastolic pressure
High vs. normal
High vs. missing
Procedure group
1
2
3
4
Trainee Present
General anesthesia vs. IV
sedation
Hospital characteristics
Adult cases >35% of total
University hospital
Annual catheterization volume (per
300 cases)

0.75 (0.51 to 1.10)
1.19 (0.88 to 1.61)
1 (n/a)
1.25 (0.93 to 1.69)
1.27 (0.79 to 2.05)
0.89 (0.73 to 1.07)

0.14
0.27
n/a
0.14
0.33
0.22

1 (n/a)
1.04 (0.80 to 1.36)
1.21 (0.90 to 1.63)
0.17 (0.10 to 0.28)
1.39 (0.75 to 2.58)

n/a
0.74
0.21
<0.0001
0.30

3.02 (2.38 to 3.83)
0.97 (0.72 to 1.30)

<0.0001
0.82

2.69 (1.13 to 6.39)
0.58 (0.39 to 0.85)
0.76 (0.57 to 1.00)
2.42 (1.49 to 3.92)

0.02
0.005
0.05
0.0003

0.96 (0.77 to 1.20)
1.22 (0.87 to 1.71)

0.71
0.21

1.36 (1.05 to 1.76)
1.22 (0.87 to 1.71)

0.02
0.25

0.95 (0.73 to 1.23)
1.07 (0.82 to 1.40)

1.07
0.61

0.87 (0.57 to 1.32)
1.15 (0.92 to 1.44)

0.50
0.21

1 (n/a)
0.68 (0.50 to 0.94)
0.73 (0.52 to 1.00)
0.91 (0.62 to 1.32)
0.97 (0.75 to 1.25)
1.19 (0.82 to 1.75)

n/a
0.02
0.05
0.62
0.81
0.36

0.17 (0.05 to 0.55)
1.03 (0.74 to 1.42)
0.68 (0.56 to 0.83)

0.003
0.88
0.0002

Table S5. Multivariable model for failure to rescue with hospital volume as the only hospital
characteristic.
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Age group
<30 days
30 days to 1 year
1 year to 8 years
8 years to 18 years
≥18 years
Male sex
Race
White
Black
Other
Surgery (previous 30 days)
Catheterization (previous 30 days)
Pre-procedure medications
Inotrope
Vasodilators
Pre-procedure conditions
Sepsis
Chronic lung disease
Genetic syndrome
Renal insufficiency
Systemic arterial saturation
Low vs. normal
Low vs. missing
Mixed venous saturation
Low vs. normal
Low vs. missing
Pulmonary artery pressure
High vs. normal
High vs. missing
Systemic ventricular end-diastolic
pressure
High vs. normal
High vs. missing
Procedure group
1
2
3
4
Trainee Present
General anesthesia vs. IV sedation
Hospital characteristics
Annual catheterization volume (per
300 cases)

OR (95% CI)

p

0.82 (0.57 to 1.19)
1.21 (0.90 to 1.62)
1 (n/a)
1.30 (0.97 to 1.74)
1.26 (0.78 to 2.02)
0.89 (0.74 to 1.07)

0.31
0.21
n/a
0.08
0.34
0.21

1 (n/a)
1.04 (0.8 to 1.34)
1.20 (0.89 to 1.61)
0.16 (0.10 to 0.25)
1.26 (0.72 to 2.18)

n/a
0.78
0.23
<0.0001
0.42

3.05 (2.43 to 3.84)
0.96 (0.72 to 1.28)

<0.0001
0.78

2.22 (0.96 to 5.14)
0.63 (0.44 to 0.91)
0.75 (0.57 to 0.98)
2.41 (1.54 to 3.78)

0.06
0.01
0.04
0.0001

0.95 (0.77 to 1.19)
1.16 (0.80 to 1.69)

0.67
0.43

1.41 (1.10 to 1.80)
1.23 (0.89 to 1.70)

0.007
0.21

1.00 (0.78 to 1.29)
1.09 (0.85 to 1.42)

0.99
0.49

0.85 (0.57 to 1.29)
1.14 (0.92 to 1.42)

0.45
0.23

1 (n/a)
0.70 (0.51 to 0.95)
0.72 (0.53 to 0.99)
0.89 (0.62 to 1.28)
0.89 (0.70 to 1.15)
1.20 (0.83 to 1.73)

n/a
0.02
0.05
0.53
0.38
0.34

0.73 (0.59 to 0.9)

0.003

Table S6. Multivariable model for failure to rescue with “university hospital” as the only hospital
characteristic.
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Age group
<30 days
30 days to 1 year
1 year to 8 years
8 years to 18 years
≥18 years
Male sex
Race
White
Black
Other
Surgery (previous 30 days)
Catheterization (previous 30 days)
Preprocedure medications
Inotrope
Vasodilators
Preprocedure conditions
Sepsis
Chronic lung disease
Genetic syndrome
Renal insufficiency
Systemic arterial saturation
Low vs. normal
Low vs. missing
Mixed venous saturation
Low vs. normal
Low vs. missing
Pulmonary artery pressure
High vs. normal
High vs. missing
Systemic ventricular end-diastolic
pressure
High vs. normal
High vs. missing
Procedure group
1
2
3
4
Trainee Present
General anesthesia vs. IV sedation
Hospital characteristics
University hospital

OR (95% CI)

p

0.83 (0.57 to 1.21)
1.21 (0.90 to 1.63)
1 (n/a)
1.30 (0.97 to 1.74)
1.29 (0.8 to 2.07)
0.89 (0.74 to 1.07)

0.33
0.20
n/a
0.08
0.29
0.89

1 (n/a)
1.04 (0.81 to 1.34)
1.20 (0.89 to 1.61)
0.16 (0.10 to 0.25)
1.25 (0.72 to 2.17)

n/a
0.76
0.23
<0.0001
0.43

3.03 (2.41 to 3.80)
0.95 (0.72 to 1.27)

<0.0001
0.74

2.22 (0.95 to 5.15)
0.63 (0.44 to 0.91)
0.75 (0.57 to 0.98)
2.37 (1.51 to 3.72)

0.06
0.01
0.04
0.0002

0.95 (0.76 to 1.18)
1.16 (0.80 to 1.69)

0.64
0.44

1.41 (1.10 to 1.80)
1.24 (0.89 to 1.71)

0.007
0.20

1.00 (0.78 to 1.29)
1.09 (0.84 to 1.41)

1.00
0.51

0.85 (0.56 to 1.28)
1.14 (0.92 to 1.42)

0.43
0.22

1 (n/a)
0.70 (0.51 to 0.95)
0.72 (0.53 to 0.99)
0.88 (0.61 to 1.27)
0.83 (0.65 to 1.06)
1.21 (0.84 to 1.76)

n/a
0.02
0.04
0.49
0.14
0.31

0.89 (0.61 to 1.30)

0.55

Table S7. Multivariable model for failure to rescue with large volume adult hospital as the only
hospital characteristic.
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Age group
<30 days
30 days to 1 year
1 year to 8 years
8 years to 18 years
≥18 years
Male sex
Race
White
Black
Other
Surgery (previous 30 days)
Catheterization (previous 30 days)
Preprocedure medications
Inotrope
Vasodilators
Preprocedure conditions
Sepsis
Chronic lung disease
Genetic syndrome
Renal insufficiency
Systemic arterial saturation
Low vs. normal
Low vs. missing
Mixed venous saturation
Low vs. normal
Low vs. missing
Pulmonary artery pressure
High vs. normal
High vs. missing
Systemic ventricular end-diastolic
pressure
High vs. normal
High vs. missing
Procedure group
1
2
3
4
Trainee Present
General anesthesia vs. IV sedation
Hospital characteristics
Adult cases >35% of total

OR (95% CI)

p

0.83 (0.57 to 1.20)
1.22 (0.91 to 1.64)
1 (n/a)
1.30 (0.97 to 1.74)
1.31 (0.82 to 2.11)
0.88 (0.73 to 1.06)

0.32
0.19
n/a
0.08
0.26
0.19

1 (n/a)
1.04 (0.81 to 1.35)
1.20 (0.89 to 1.61)
0.16 (0.1 to 0.25)
1.23 (0.71 to 2.13)

n/a
0.74
0.23
<0.0001
0.47

3.01 (02.40 to 3.79)
0.95 (0.72 to 1.26)

<0.0001
0.73

2.18 (0.94 to 5.06)
0.63 (0.44 to 0.91)
0.76 (0.58 to 0.99)
2.37 (1.51 to 3.72)

0.07
0.01
0.01
0.0002

0.95 (0.76 to 1.18)
1.16 (0.80 to 1.69)

0.64
0.44

1.39 (1.09 to 1.79)
1.23 (0.89 to 1.71)

0.009
0.21

1.00 (0.78 to 1.29)
1.10 (0.85 to 1.43)

0.99
0.47

0.85 (0.57 to 1.28)
1.15 (0.93 to 1.43)

0.45
0.20

1 (n/a)
0.70 (0.51 to 0.96)
0.72 (0.52 to 0.99)
0.88 (0.61 to 1.27)
0.84 (0.66 to 1.08)
1.21 (0.83 to 1.75)

n/a
0.03
0.04
0.50
0.17
0.32

0.22 (0.06 to 0.78)

0.02

